COVID 19: Evaluate of Liver and Renal Function Tests in Iraqi Patients
Keywords:COVID 19; liver enzyme;urea; creatinine; AST, ALT
The clinical features of COVID-19 are varied, ranging from asymptomatic state to acute respiratory distress
syndrome and multi organ dysfunction. We aim to evaluate renal and liver functions of patients with COVID
19. Laboratory results were obtained from 107 patients with laboratory-confirmed COVID-19 whowere
admitted to the only Al-Furat General Hospital in Baghdad, Iraq from March 3 to June 9, 2020 and followed
up until recovery. Normal levels of renal functions were presented. Meanwhile elevated levels of alanine
aminotransferase (ALT) was observed in 10% and of aspartate aminotransferase (AST) was observed in
40% of patients with COVID 19,yet on comparison of the results at entering with at recovery it was observed
significant differences (p<0.01) of all patients. From these findings we conclude that the virus might be
responsible for systemic inflammation.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.